TrialBritish journal of cancer2023

Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumors.

Jason J Luke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.